Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (11-20 of 250) with videos related to

Pageof 25
Sort By:
Expert Review of Vaccines|December 12, 2018
The 5th virus-like particle and nano-particle vaccines (VLPNPV) conferencePaul Engeroff, Martin F Bachmann
Expert Opinion on Investigational Drugs|November 1, 2007
Vaccination against nicotine: an emerging therapy for tobacco dependencePatrik Maurer, Martin F Bachmann
Expert Review of Vaccines|May 4, 2012
Immunization strategies for Clostridium difficile infectionsFabien Rebeaud, Martin F Bachmann
Current Opinion in Immunology|June 29, 2002
Balancing protective immunity and immunopathologyMartin F Bachmann, Manfred Kopf
Advances in Experimental Medicine and Biology|October 31, 2007
Targeting osteoporosis and rheumatoid arthritis by active vaccination against RANKLGunther Spohn, Martin F Bachmann
Clinical Immunology (Orlando, Fla.)|July 7, 2009
Immunization against angiotensins for the treatment of hypertensionPatrik Maurer, Martin F Bachmann
Expert Opinion on Biological Therapy|June 5, 2003
Therapeutic vaccination to block receptor-ligand interactionsGunther Spohn, Martin F Bachmann
Immunological Investigations|May 11, 2010
T cell-dependent and -independent IgA responses: role of TLR signallingJuliana Bessa, Martin F Bachmann
Viruses|August 14, 2020
Special Issue "Virus-Like Particle Vaccines"Monique Vogel, Martin F Bachmann
Human Vaccines|June 5, 2010
Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG?Thomas M Kündig, Martin F Bachmann
Pageof 25

Showing results (11-20 of 250) with videos related to

Sort By:
Pageof 25
Expert Review of Vaccines|December 12, 2018
The 5th virus-like particle and nano-particle vaccines (VLPNPV) conferencePaul Engeroff, Martin F Bachmann
Expert Opinion on Investigational Drugs|November 1, 2007
Vaccination against nicotine: an emerging therapy for tobacco dependencePatrik Maurer, Martin F Bachmann
Expert Review of Vaccines|May 4, 2012
Immunization strategies for Clostridium difficile infectionsFabien Rebeaud, Martin F Bachmann
Current Opinion in Immunology|June 29, 2002
Balancing protective immunity and immunopathologyMartin F Bachmann, Manfred Kopf
Advances in Experimental Medicine and Biology|October 31, 2007
Targeting osteoporosis and rheumatoid arthritis by active vaccination against RANKLGunther Spohn, Martin F Bachmann
Clinical Immunology (Orlando, Fla.)|July 7, 2009
Immunization against angiotensins for the treatment of hypertensionPatrik Maurer, Martin F Bachmann
Expert Opinion on Biological Therapy|June 5, 2003
Therapeutic vaccination to block receptor-ligand interactionsGunther Spohn, Martin F Bachmann
Immunological Investigations|May 11, 2010
T cell-dependent and -independent IgA responses: role of TLR signallingJuliana Bessa, Martin F Bachmann
Viruses|August 14, 2020
Special Issue "Virus-Like Particle Vaccines"Monique Vogel, Martin F Bachmann
Human Vaccines|June 5, 2010
Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG?Thomas M Kündig, Martin F Bachmann
Pageof 25